SCHEMBL20766869

SCHEMBL20766869

CN1CCC(CC(=O)N(Cc2ccc(F)cc2)Cc2ccc(F)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.50
KCNH2 Q12809 3/20 0.46
MCHR1 Q99705 2/20 0.46
OPRM1 P35372 3/20 0.45
CHRM1 P11229 2/20 0.45
CHRM5 P08912 1/20 0.45
CHRM3 P20309 1/20 0.45
TMEM97 Q5BJF2 1/20 0.43
ABCB11 O95342 1/20 0.43
CYP1A2 P05177 1/20 0.43
ADRB2 P07550 1/20 0.43
CHRM2 P08172 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2C P28335 1/20 0.43
GPR183 P32249 1/20 0.43
CYP2C19 P33261 1/20 0.43
ADRA1A P35348 1/20 0.43
APLNR P35414 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767249 0.92 HTR2A (0.52) HTR2AKCNH2MCHR1OPRM1CHRM1
SCHEMBL20766920 0.91 HTR2A (0.56) HTR2AKCNH2OPRM1CHRM1ABCB11
SCHEMBL20767191 0.84 HTR2A (0.57) HTR2AMCHR1OPRM1CHRM1CHRM5
SCHEMBL20767178 0.82 HTR2A (0.53) HTR2A
SCHEMBL20767250 0.81 HTR2A (0.67) HTR2A
SCHEMBL20781011 0.81 HTR2A (0.50) HTR2A
SCHEMBL20767208 0.81 HTR2A (0.52) HTR2AOPRM1
SCHEMBL20767254 0.80 HTR2A (0.56) HTR2A
SCHEMBL20767185 0.79 HTR2A (0.53) HTR2A
SCHEMBL20767243 0.75 ALDH1A1 (0.46) HTR2AOPRM1CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed